¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

APCCMI 2023 & ´ëÇÑÀÓ»ó¹Ì»ý¹°ÇÐȸ Á¦26Â÷ Çмú´ëȸ (1ÀÏÂ÷) : 2023-07-06

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

APCCMI 2023 & ´ëÇÑÀÓ»ó¹Ì»ý¹°ÇÐȸ Á¦26Â÷ Çмú´ëȸ (1ÀÏÂ÷) : 2023-07-06
±³À°ÀÏÀÚ : 2023-07-06
±³À°Àå¼Ò : ¼­¿ï ÄÚ¿¢½º 1Ãþ Grand Ballroom 101È£ ¿Ü 6°³·ë

±³À°ÁÖÁ¦ : APCCMI 2023 & ´ëÇÑÀÓ»ó¹Ì»ý¹°ÇÐȸ Á¦26Â÷ Çмú´ëȸ (1ÀÏÂ÷)

ÁÖÃÖ±â°ü : ´ëÇÑÀÓ»ó¹Ì»ý¹°ÇÐȸ
´ã´çÀÚ : ÀÌÇüÁÖ
¿¬¶ôó : 02-401-1570  

À̸ÞÀÏ : kscm.office@gmail.com

±³À°Á¾·ù : ³»°ú, Áø´Ü°Ë»çÀÇÇаú, º´¸®°ú, ¹Ì»ý¹°ÇÐ

Âü¼®¿¹»óÀÎ : 1000¸í
Èñ¸ÁÆòÁ¡ : 6Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 19 ½Ã°£ 55ºÐ

¼¼ºÎ¼ö°­·á : 775,000¿ø  

ºñ°í Early Bird Registration: Regular - Member USD 400, Regular – Non-member USD 500 / Pre-registration: Regular - Member USD 500, Regular – Non-member USD 600 / Trainee USD 200


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 07¿ù 06ÀÏ Grand Ballroom 101~103 09:00~09:45 SARS-CoV-2 variants, vaccines, and immunity Eui-Cheol Shin(Korea Advanced Institute of Science and Technology, Korea)

±³À°½Ã°£ 07¿ù 06ÀÏ Grand Ballroom 101~103 09:45~10:30 Cancer and COVID-19 Murat Akova(Hacettepe University, Turkey)

ÈÞ½Ä 07¿ù 06ÀÏ 10:30~10:45 ()

±³À°½Ã°£ 07¿ù 06ÀÏ Grand Ballroom 101~103 10:45~11:10 Viral Special Pathogen Leo Poon(University of Hong Kong, Hong Kong, China)

±³À°½Ã°£ 07¿ù 06ÀÏ Grand Ballroom 101~103 11:10~11:35 National Laboratory Preparedness against High Risk Pathogens Hwajung Yi(Korea Disease Control and Prevention Agency, Korea)

±³À°½Ã°£ 07¿ù 06ÀÏ Grand Ballroom 101~103 11:35~12:00 Monkeypox: Epidemiology, Transmission Dynamics, and IPC Strategies Marimuthu Kalisvar(National University of Singapore, Singapore)

±³À°½Ã°£ 07¿ù 06ÀÏ ASEM Room 1 10:45~11:10 Antifungal Resistance in Candida glabrata Jong Hee Shin(Chonnam National University, Korea)

±³À°½Ã°£ 07¿ù 06ÀÏ ASEM Room 1 11:10~11:35 Fungemia Due to Uncommon Candida spp Murat Akova(Hacettepe University, Turkey)

±³À°½Ã°£ 07¿ù 06ÀÏ ASEM Room 1 11:35~12:00 MDR Candida auris Emergence in Asia Pacific Anuradha Chowdhary(Vallabhbhai Patel Chest Institute, University of Delhi, India)

±³À°½Ã°£ 07¿ù 06ÀÏ ASEM Room 2 10:45~11:10 Resistance Mechanisms and epidemiology in Asia-Pacific Region Anucha Apisarnthanarak(Thammasat University, Thailand)

±³À°½Ã°£ 07¿ù 06ÀÏ ASEM Room 2 11:10~11:35 Core Elements for the Implementation of Antimicrobial Stewardship Programs in Healthcare Facilities Ki Tae Kwon(Kyungpook National University, Korea)

±³À°½Ã°£ 07¿ù 06ÀÏ ASEM Room 2 11:35~12:00 Addressing Antimicrobial Stewardship Gap in Asia Pacific region David Lye(Tan Tong Seng Hospital, Singapore)

ÈÞ½Ä 07¿ù 06ÀÏ 12:00~12:20 ()

±³À°½Ã°£ 07¿ù 06ÀÏ Grand Ballroom 101+102 12:20~12:50 Current challenges in molecular diagnostics of BK virus infection In Young Yoo(The Catholic University of Korea, Korea)

±³À°½Ã°£ 07¿ù 06ÀÏ Grand Ballroom 101+102 12:50~13:20 Importance of CMV, EBV and BKV viral load monitoring and standardization in transplant patient management Young Ho Lee(Roche Diagnostics Korea Co., Ltd., Korea)

±³À°½Ã°£ 07¿ù 06ÀÏ Grand Ballroom 103 12:20~12:50 Pfizer Comirnaty James Baber(Clinician Medical Monitor at Pfizer, Australia)

Åä·Ð 07¿ù 06ÀÏ Grand Ballroom 103 12:50~13:20 Panel Discussion ()

±³À°½Ã°£ 07¿ù 06ÀÏ ASEM Room 1 12:20~13:20 Devising Diagnostic Pathway & AMR Murray Robinson(Pathlab, New Zealand)

±³À°½Ã°£ 07¿ù 06ÀÏ ASEM Room 2 12:20~13:20 How Has Multiplex PCR Testing Changed Physicians¡¯ Prescribing Behaviors in Emergency Department? – A Paradigm Shift in The Management of Respiratory Tract Infections Chien-Chang Lee(National Taiwan University Hospital, Taiwan)

Åä·Ð 07¿ù 06ÀÏ ASEM Room 1 13:20~14:00 Poster Presentation 1 ()

±³À°½Ã°£ 07¿ù 06ÀÏ Grand Ballroom 101~103 14:00~14:25 Genomic Epidemiological Analysis of AMR Bacteria Using a Novel Plasmid Replicon Database Masato Suzuki(National Institute of Infectious Diseases, Japan)

±³À°½Ã°£ 07¿ù 06ÀÏ Grand Ballroom 101~103 14:25~14:50 Sepsis and AMR Diagnosis in ICUs: POCT, Syndromic Testings, and mNGS Po-Ren Hsueh(China Medical University Hospital, Taiwan)

±³À°½Ã°£ 07¿ù 06ÀÏ Grand Ballroom 101~103 14:50~15:15 Expansion of the Mass Spectrometry Realm from Microbial Identification to Beyond Yumi Kubo(FALCO Biosystems, Japan)

±³À°½Ã°£ 07¿ù 06ÀÏ Grand Ballroom 101~103 15:15~15:40 Innovative Ways to Drive Change in Antibiotic Stewardship Program; Fast and Direct Antibiotic Susceptibility Testing Mi-Na Kim(Asan Medical Center, University of Ulsan, Korea)

±³À°½Ã°£ 07¿ù 06ÀÏ ASEM Room 1 14:00~14:25 Updates on New APSIC Guideline - Prevention of CAUTI Patricia Ching(WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, University of Hong Kong, Hong Kong, China)

±³À°½Ã°£ 07¿ù 06ÀÏ ASEM Room 1 14:25~14:50 New Disinfection Methods for Medical Instruments Ji Young Lee(Seoul ST. Mary¡¯s Hospital, Korea)

±³À°½Ã°£ 07¿ù 06ÀÏ ASEM Room 1 14:50~15:15 Evolution of Rapid Diagnostic Tests and Identification of Molecular Basis for Antimicrobial Resistance in Limited Resource Countries Namita Jaggi(Artemis Hospital, India)

±³À°½Ã°£ 07¿ù 06ÀÏ ASEM Room 1 15:15~15:40 Implementing Genomics from Outbreak Investigation to Routine Surveillance Hyuk Min Lee(Yonsei University, Korea)

±³À°½Ã°£ 07¿ù 06ÀÏ ASEM Room 2 14:00~14:25 Healthcare-Associated Infections and Outbreak of COVID-19 Angela Chow(Tan Tock Seng Hospital, Singapore)

±³À°½Ã°£ 07¿ù 06ÀÏ ASEM Room 2 14:25~14:50 The Impact of COVID-19 on Healthcare-Associated Infections Susan Huang(University of California, Irvine School of Medicine, USA)

±³À°½Ã°£ 07¿ù 06ÀÏ ASEM Room 2 14:50~15:15 Changes in Major AMR Trends amidst the COVID-19 Pandemic Dokyun Kim(Yonsei University, Korea)

±³À°½Ã°£ 07¿ù 06ÀÏ ASEM Room 2 15:15~15:40 Prevention of Infection by Multidrug-resistant Organism in Severe COVID-19 Patients Le Thi Anh Thu(Cho Ray Hospital, Vietnam)

ÈÞ½Ä 07¿ù 06ÀÏ 15:40~16:00 ()

±³À°½Ã°£ 07¿ù 06ÀÏ Grand Ballroom 101~103 16:00~16:25 National Antimicrobial Usage Monitoring Program: The Reference for Hospital-based Intervention Bongyoung Kim(Hanyang University, Korea)

±³À°½Ã°£ 07¿ù 06ÀÏ Grand Ballroom 101~103 16:25~16:50 Mission Impossible Success to Treat XDR or PDR Gram Negative Rods with Reuse or Novel Drugs Balaji Veeraraghavan(Christian Medical College Vellore, India)

±³À°½Ã°£ 07¿ù 06ÀÏ Grand Ballroom 101~103 16:50~17:15 Appling MALDI-TOF MS and Machine Learning for Antibiotic Resistance Prediction Jiaxin Yu(China Medical University Hospital, Taiwan)

±³À°½Ã°£ 07¿ù 06ÀÏ Grand Ballroom 101~103 17:15~17:40 Power of Rapid Molecular Diagnostics in the Battle of MDR-GNR Katsunori Yanagihara(Nagasaki University, Japan)

±³À°½Ã°£ 07¿ù 06ÀÏ ASEM Room 1 16:00~16:25 Global Threat of Carbapenem-Resistant Gram-Negative Bacteria Po-Ren Hsueh(China Medical University Hospital, Taiwan)

±³À°½Ã°£ 07¿ù 06ÀÏ ASEM Room 1 16:25~16:50 Recent Advances in Detection Methods for Carbapenemase-producing Enterobacterales Kosuke Kosai(Nagasaki University Hospital, Japan)

±³À°½Ã°£ 07¿ù 06ÀÏ ASEM Room 1 16:50~17:15 Treatment Strategies for CPE Infections Yohei Doi(Center for Innovative Antimicrobial Therapy, University of Pittsburg, USA)

±³À°½Ã°£ 07¿ù 06ÀÏ ASEM Room 1 17:15~17:40 Infection Control for CRE: Recent Advances Zhiyong Zong(West China Hospital, Sichuan University, China)

±³À°½Ã°£ 07¿ù 06ÀÏ ASEM Room 2 16:00~16:25 Lights and Shadows of Test-Trace-Treatment Policy against the COVID-19 Pandemic Tongryoung Jung(Korean Disease Control and Prevention Agency, Korea)

±³À°½Ã°£ 07¿ù 06ÀÏ ASEM Room 2 16:25~16:50 Lesson Learnt from COVID-19 and Better Preparation for Laboratory Capacity against Pandemic X Kenji Ota(Nagasaki University Hospital, Japan)

±³À°½Ã°£ 07¿ù 06ÀÏ ASEM Room 2 16:50~17:15 National Response to the COVID-19 Pandemic and Preparation for Pandemic X Dandu Chandrasekhar Reddy(Banaras Hindu University & WHO-India, India)

±³À°½Ã°£ 07¿ù 06ÀÏ ASEM Room 2 17:15~17:40 Risk Management and Communication in Public Health Crisis by COVID-19 or Future Pandemic Paul Anantharajah Tambyah(National University of Singapore, Singapore)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" APCCMI 2023 & ´ëÇÑÀÓ»ó¹Ì»ý¹°ÇÐȸ Á¦26Â÷ Çмú´ëȸ (1ÀÏÂ÷) : 2023-07-06""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û (¿Â¶óÀÎ) Á¦ 5ȸ °¡Å縯´ëÇб³ ¼ººó¼¾Æ® ¾Ïº´¿ø ½ÉÆ÷Áö¾ö : 2023-07-07
´ÙÀ½±Û ´ëÇÑ°£¾ÏÇÐȸ APPLE 2023 (The 13th Asia-Pacific Primary Liver Cancer Expert Meeting) - Day1 : 2023-07-06
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20477 ºÎ»ê ´ëÇÑ°£ÇÐȸ ºÎ»ê¿ï»ê°æ³²Áöȸ Áý´ãȸ(°£¼¼Æ÷¾ÏÀÇ downstaging: Çö½Ç°ú ¹Ì·¡) : 2024-05-09 0 126 2024-04-29
20476 ÀÎõ Çѱ¹¿©ÀÚÀÇ»çȸ ÀÎõÁöȸ 5¿ù Çмú½ÉÆ÷Áö¾ö : 2024-05-09 0 91 2024-04-29
20475 Á¦ÁÖ ´ëÇÑ°áÇÙ ¹× È£Èí±âÇÐȸ Á¦ÁÖÁöȸ 5¿ù ¿¬¼ö°­Á : 2024-05-08 0 96 2024-04-29
20474 Á¦ÁÖ (3ÀÏÂ÷) 2024³â Á¦24Â÷ Çѱ¹Á¶Á÷°øÇС¤Àç»ýÀÇÇÐȸ Á¤±âÇмú´ëȸ : 2024-05-04 0 174 2024-04-29
20473 Á¦ÁÖ (2ÀÏÂ÷) 2024³â Á¦24Â÷ Çѱ¹Á¶Á÷°øÇС¤Àç»ýÀÇÇÐȸ Á¤±âÇмú´ëȸ : 2024-05-03 0 75 2024-04-29
20472 ÀüºÏ ´ëÇÑÇǺÎÁø±Õ ¹× °¨¿°ÇÐȸ ¼øȸ¿¬¼ö±³À° : 2024-05-03 0 96 2024-04-29
20471 Á¦ÁÖ (1ÀÏÂ÷) 2024³â Á¦24Â÷ Çѱ¹Á¶Á÷°øÇС¤Àç»ýÀÇÇÐȸ Á¤±âÇмú´ëȸ : 2024-05-02 0 102 2024-04-29
20470 ´ë±¸ Á¦ 263Â÷ ´ëÇÑ ÇǺΰúÇÐȸ ´ë±¸°æºÏÁöºÎ Áý´ãȸ(¿øÇü Å»¸ð) : 2024-05-02 0 145 2024-04-29
20469 ±¤ÁÖ ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ±¤ÁÖÀü³²Áöȸ Á¦51Â÷ ÇмúÁý´ãȸ : 2024-05-02 0 185 2024-04-29
20468 ºÎ»ê ´ëÇÑÀ忬±¸ÇÐȸ ºÎ¿ï°æÁöȸ Á¤±âÁý´ãȸ : 2024-04-29 0 111 2024-04-29
20467 ¼­¿ï 2024 ´ëÇÑÇ÷¾×ÇÐȸ Á¶Á÷±¸Áõ½ÄÁõ¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2024-05-31 0 289 2024-04-17
20466 °æ±â ¾ÆÁִ뺴¿ø ÀÀ±ÞÀÇÇаú ¼³¸³ 30Áֳ⠱â³ä ½ÉÆ÷Áö¿ò : 2024-05-30 0 196 2024-04-17
20465 ¼­¿ï Á¦20Â÷ ´ëÇѸð¹ßÇÐȸ Çмú´ëȸ ÇÁ·Î±×·¥ : 2024-05-26 0 160 2024-04-17
20464 °æ±â 2024³â Á¦86Â÷ ´ëÇÑ»ý½ÄÀÇÇÐȸ Ãá°èÇмú´ëȸ : 2024-05-26 0 202 2024-04-17
20463 ¼­¿ï 2024³â ´ëÇѼҾƼÒÈ­±â¿µ¾çÇÐȸ Ãá°è ½ÉÆ÷Áö¾ö : 2024-05-26 0 240 2024-04-17
41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷